The Valley Desk

NCT05935085 · Interventional trial

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

Overall registry status Terminated

Phase 2

Conditions Atopic Dermatitis Eczema

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov